The S&P 500 has strung together back-to-back winning days though it remains down 3.3 percent so far in 2025. Investors have been trading through patterns similar to 2022, when the Federal Reserve’s ...

making it one of the most expensive therapies in the U.S. Mizuho said the selling of the stock was likely an overreaction, noting that this is the first case of acute liver failure among patients ...

BlackBerry’s history of success and failure as the world’s first smartphone maker will now be featured in a movie.

Get frequent stock market updates that focus on broad U.S. and international markets approximately every half-hour starting at 6 a.m. ET with foreign market and U.S. futures summaries and market ...

Sarepta Therapeutics Inc.'s stock was down 21.6% in premarket trades on Tuesday after the commercial-stage biopharmaceutical company said a patient died from liver failure after using its drug ...

Robinhood Markets (NASDAQ:HOOD) is facing heat again, with its stock tumbling 13% Monday morning ... by not fully explaining how it converted market orders into limit orders through a practice ...

The company said that more than 800 people have been treated with Elevidys, with only one experiencing liver failure.